Published on : May 23, 2018
Albany, New York, May 23, 2018: The profile of Parkinson's disease has certainly risen in recent years, and this tends to be a very frightening disease to be diagnosed with. According to a latest study findings, the global Parkinson’s disease therapeutics market is witnessing a relatively high growth owing to rise in awareness regarding Parkinson’s disease, rapidly growing geriatric population, promising pipeline drugs, and new product launches. In order to provide a comprehensive view of the market, a study titled “Parkinson’s disease Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 – 2025” has been added to the massive archive of Market Research Hub (MRH), which provide wide-ranging insights into the market current scenario and future growth prospects during the mentioned forecast period of 2017-2025.
Snapshot and Forecast Predictions
Parkinson's disease is a condition in which parts of the brain become progressively damaged over many years. It primarily causes tremors, muscle stiffness, improper motor movements, and gait and balance problems. The exact cause of the disease is still unknown, which is why the therapeutic area has become more active for this disease. It is estimated that worldwide around 7 to 10 million people are affected by disease and every year around 60,000 Americans are diagnosed with it. Rise in incidence rates of Parkinson’s disease in developed countries are motivating the growth of the global market. According to the study prime findings, the global Parkinson’s disease therapeutics market is projected to witness CAGR of more than 10.9% from 2017 to 2025, and to exceed the US$ 5.24 Bn by 2025. In 2016, the market was valued at US$ 2.18 Bn.
The market overview section of the report explores the market dynamics such as drivers, restraints, opportunities, and pipeline drugs that currently have a strong impact on the Parkinson’s disease therapeutics market and is likely to influence the market in the near future. In this study, market attractiveness analysis has been also provided in the market overview section in order to explain the intensity of competition in the market across different geographies. Regions highlighted in the study includes North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. From a geographical standpoint, the research observes that Europe is a highly attractive market and is expected to expand at a significant CAGR during the forecast period.
Moreover, the global Parkinson’s disease therapeutics market can be divided into four segments based on drug class, route of administration, and distribution channel. By drug class, the study levodopa combination therapy, dopamine agonists, MAO-B inhibitors, COMT inhibitors, and others. Of these, levodopa combination therapy is considered as a highly effective treatment for monitoring the motor symptoms throughout the stages of Parkinson’s disease. By route of administration, the study highlights oral, transdermal, subcutaneous, intestinal infusion, and others.
Another vital section of the report is competitive landscape featuring some of the top companies in Parkinson’s disease therapeutics market. They include AbbVie Inc., Novartis AG, F. Teva Pharmaceutical Industries Ltd., Hoffmann-La Roche AG, and UCB Inc, which exhibit the widest geographical outreach.
Request a Sample with TOC in a PDF format : https://www.marketresearchhub.com/enquiry.php?type=S&repid=1772203
About Market Research Hub
Market Research Hub (MRH) is a next-generation reseller of research reports and analysis. MRH’s expansive collection of market research reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.
MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients.
For Enquiries, Call :
+1-800-998-4852US Toll Free
Email : email@example.com